MEMORANDUM AND ORDER ON AMGEN'S RENEWED MOTION FOR SUMMARY ADJUDICATION OF CLAIM 9 OF THE `702 PATENT
STEARNS, District Judge.
Biogen brought suit alleging among other wrongs that Amgen's product Neupogen® infringes claim 9 of U.S. Patent 4,874,702 (the "`702 patent").
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.